Detalles de la búsqueda
1.
Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a residential setting.
Am J Addict
; 31(2): 142-147, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137481
2.
A Randomized Controlled Trial of an Integrated Alcohol Reduction Intervention in Patients With Hepatitis C Infection.
Hepatology
; 71(6): 1894-1909, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31803945
3.
Patterns of withdrawal in patients with opioid use disorder (OUD) transitioning from untreated OUD or buprenorphine treatment to extended-release naltrexone.
Am J Drug Alcohol Abuse
; 47(6): 753-759, 2021 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34752714
4.
Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Use Disorder and Serious Mental Illness.
Nicotine Tob Res
; 22(9): 1533-1542, 2020 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31667501
5.
Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended-Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens.
Am J Addict
; 29(4): 313-322, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32246728
6.
Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone.
Am J Addict
; 27(6): 471-476, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30028058
7.
Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies.
Am J Addict
; 27(3): 177-187, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29596725
8.
Heroin Use in Older Adults: A Treatment Challenge.
Am J Geriatr Psychiatry
; 29(5): 426-428, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33640267
9.
Erratum to: Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals With Co-Occurring Tobacco Dependence and Serious Mental Illness.
Nicotine Tob Res
; 23(2): 411, 2021 01 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761194
10.
Clinical epidemiology of substance use disorders: Understanding patterns, sharing knowledge, planning interventions.
Indian J Med Res
; 149(4): 443-445, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31411168
11.
Opioid use disorder deaths and the effects of medication therapy.
Am J Drug Alcohol Abuse
; 45(3): 227-229, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30849238
12.
Smoking and opioid detoxification: behavioral changes and response to treatment.
Nicotine Tob Res
; 15(10): 1705-13, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23572466
13.
Pharmacy-based methadone treatment in the US: views of pharmacists and opioid treatment program staff.
Subst Abuse Treat Prev Policy
; 18(1): 55, 2023 09 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697326
14.
Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S.
Addict Sci Clin Pract
; 18(1): 45, 2023 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533071
15.
Alcohol and drug use disorders among adults in emergency department settings in the United States.
Ann Emerg Med
; 60(2): 172-80.e5, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22424657
16.
An integrated alcohol abuse and medical treatment model for patients with hepatitis C.
Dig Dis Sci
; 57(4): 1083-91, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22134784
17.
The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal.
Am J Drug Alcohol Abuse
; 38(3): 200-5, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22233189
18.
Association of chronic non-cancer pain status and buprenorphine treatment retention among individuals with opioid use disorder: Results from electronic health record data.
Drug Alcohol Depend Rep
; 3: 100048, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36845986
19.
Family substance use screening: less to hide, more to gain.
Indian J Med Res
; 143(6): 682-684, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27748291
20.
Buprenorphine physician-pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network.
Addiction
; 116(7): 1805-1816, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428284